Applied StemCell Stock
Applied StemCell is a biotechnology company providing animal and cell line models as tools for drug discovery and diagnostics.
Sign up today and learn more about Applied StemCell Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Applied StemCell Stock
Applied StemCell Inc. (ASC) is a fast growing biotechnology company providing animal and cell line models as tools for drug discovery and diagnostics. Using our proprietary TARGATT™ gene modification technology, we make site-specific Knockin mouse, rat and human cell line models fast and efficient for pharmaceutical and academic community. Based on our Proprietary Technologies, we focus on the development and commercialization of: Mouse models (Knockin, Knockout, Transgenic, Site-specific transgenic - TARGATT™, Humanized mouse models) Rat models Human cell line model (Gene modified iPSC - adult stem cell / progenitor cells - differentiated cells) Stem cell culture products (optimized stem cell medium and reporters) Gene engineering in stem cells or other mammalian cells (e.g. generation of protein - production mammalian cell lines) We are striving to improve and expand our technologies and product lines to meet the increasing requirements of biomedical community. ASC welcomes your comments, suggestions and ideas.
Funding History
| March 2010 | $1.9M |
|---|---|
| March 2013 | $2.6M |
| June 2016 | $19.0M |
Management
Chief Executive Officer, President, and Co-Founder
Ruby Yanru Chen-Tsai
Press
biospace - Oct, 9 2023
QHP Capital Acquires Applied StemCellbusinesswire - Jun, 6 2016
Applied StemCell Secures $19 Million in Series D FinancingEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
